Biohaven Ltd (BHVN)
44.77
-8.31
(-15.66%)
USD |
NYSE |
Apr 15, 16:00
44.69
-0.08
(-0.18%)
Pre-Market: 20:00
Biohaven Free Cash Flow: -334.77M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -334.77M |
| September 30, 2023 | -295.13M |
| June 30, 2023 | -299.15M |
| Date | Value |
|---|---|
| March 31, 2023 | -358.05M |
| December 31, 2022 | -338.76M |
Free Cash Flow Range, Past 5 Years
-358.05M
Minimum
Mar 2023
-295.13M
Maximum
Sep 2023
-325.17M
Average
-334.77M
Median
Dec 2023
Free Cash Flow Benchmarks
| Eli Lilly and Co | -3.152B |
| Amgen Inc | 7.359B |
| Regeneron Pharmaceuticals Inc | 3.668B |
| Scholar Rock Holding Corp | -145.30M |
| Alnylam Pharmaceuticals Inc | 41.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -114.88M |
| Cash from Investing (Quarterly) | -3.914M |
| Cash from Financing (Quarterly) | 245.24M |
| Free Cash Flow Per Share (Quarterly) | -1.441 |
| Free Cash Flow Yield | -10.50% |